Diagnostics & Research
The Diagnostics & Research industry has a total of 49 stocks, with a combined market cap of $839.53 billion, total revenue of $166.46 billion and a weighted average PE ratio of 54.34.
Market Cap
839.53B
Revenue
166.46B
Profits
15.45B
PE Ratio
54.34
Profit Margin
9.28%
Dividend Yield
0.19%
49 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 239.06B | 2.79% | 3,206,317 | 43.74B |
| 2 | DHR | Danaher Corporation | 170.97B | 3.29% | 5,042,771 | 24.27B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 55.61B | 1.52% | 556,278 | 4.17B |
| 4 | IQV | IQVIA Holdings Inc. | 41.11B | 3.30% | 1,016,741 | 15.90B |
| 5 | A | Agilent Technologies, Inc. | 39.62B | 2.90% | 1,987,959 | 6.95B |
| 6 | NTRA | Natera, Inc. | 33.58B | 3.38% | 1,413,285 | 2.12B |
| 7 | MTD | Mettler-Toledo International Inc. | 29.48B | 2.80% | 154,801 | 3.94B |
| 8 | WAT | Waters Corporation | 23.62B | 3.35% | 518,949 | 3.11B |
| 9 | ILMN | Illumina, Inc. | 23.30B | 3.61% | 2,269,021 | 4.29B |
| 10 | LH | Labcorp Holdings Inc. | 22.31B | -0.80% | 826,323 | 13.77B |
| 11 | DGX | Quest Diagnostics Incorporated | 20.54B | -2.28% | 1,140,316 | 10.85B |
| 12 | EXAS | Exact Sciences Corporation | 19.45B | 0.13% | 1,965,292 | 3.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 17.48B | 3.02% | 251,233 | 2.36B |
| 14 | GH | Guardant Health, Inc. | 14.91B | 0.77% | 2,271,397 | 902.57M |
| 15 | ICLR | ICON Public Limited Company | 14.12B | 4.70% | 1,186,071 | 8.10B |
| 16 | RVTY | Revvity, Inc. | 13.21B | 4.15% | 2,252,754 | 2.81B |
| 17 | QGEN | Qiagen N.V. | 11.47B | 0.38% | 8,723,640 | 2.07B |
| 18 | CRL | Charles River Laboratories International, Inc. | 11.16B | 3.93% | 521,014 | 4.02B |
| 19 | RDNT | RadNet, Inc. | 5.56B | 2.20% | 693,431 | 1.97B |
| 20 | SHC | Sotera Health Company | 5.39B | 1.55% | 1,516,057 | 1.15B |
| 21 | GRAL | GRAIL, Inc. | 3.94B | -0.24% | 941,263 | 141.83M |
| 22 | BLLN | BillionToOne, Inc. | 3.85B | -2.14% | 283,603 | 254.14M |
| 23 | VCYT | Veracyte, Inc. | 3.42B | 3.86% | 593,855 | 495.14M |
| 24 | WGS | GeneDx Holdings Corp. | 2.89B | 0.36% | 651,883 | 402.19M |
| 25 | TWST | Twist Bioscience Corporation | 2.67B | 4.80% | 1,261,456 | 376.57M |
| 26 | NEOG | Neogen Corporation | 2.15B | 5.56% | 2,578,635 | 880.32M |
| 27 | NEO | NeoGenomics, Inc. | 1.64B | 0.40% | 1,714,194 | 709.16M |
| 28 | CSTL | Castle Biosciences, Inc. | 1.20B | 0.29% | 279,315 | 343.53M |
| 29 | CDNA | CareDx, Inc. | 1.07B | 3.12% | 594,760 | 358.00M |
| 30 | OPK | OPKO Health, Inc. | 1.06B | 6.98% | 6,682,344 | 642.07M |
| 31 | FLGT | Fulgent Genetics, Inc. | 860.91M | 0.58% | 150,217 | 315.55M |
| 32 | PSNL | Personalis, Inc. | 856.96M | 2.77% | 1,943,688 | 69.10M |
| 33 | MYGN | Myriad Genetics, Inc. | 544.37M | 2.82% | 1,005,959 | 825.30M |
| 34 | BNR | Burning Rock Biotech Limited | 334.41M | 1.77% | 19,297 | 75.75M |
| 35 | PRE | Prenetics Global Limited | 275.48M | 0.86% | 276,443 | 77.08M |
| 36 | MDXH | MDxHealth SA | 192.05M | 8.38% | 112,091 | 103.07M |
| 37 | IMDX | Insight Molecular Diagnostics Inc. | 186.61M | 5.85% | 21,366 | 4.40M |
| 38 | FONR | FONAR Corporation | 122.44M | -0.21% | 86,043 | 105.43M |
| 39 | XGN | Exagen Inc. | 107.20M | -0.21% | 771,841 | 63.60M |
| 40 | BDSX | Biodesix, Inc. | 86.88M | 22.42% | 1,038,219 | 80.17M |
| 41 | PRPO | Precipio, Inc. | 43.26M | -0.04% | 4,254 | 22.80M |
| 42 | NOTV | Inotiv, Inc. | 18.99M | 1.94% | 177,300 | 513.02M |
| 43 | MYNZ | Mainz Biomed N.V. | 10.69M | 7.27% | 569,878 | 659.94K |
| 44 | MBAI | Check-Cap Ltd. | 10.28M | -0.59% | 1,759 | - |
| 45 | ADVB | Advanced Biomed Inc. | 7.07M | 0.52% | 31,823 | - |
| 46 | BIAF | bioAffinity Technologies, Inc. | 5.88M | - | 67,876 | 6.78M |
| 47 | NDRA | ENDRA Life Sciences Inc. | 5.03M | -8.88% | 174,359 | - |
| 48 | ISPC | iSpecimen Inc. | 3.18M | -5.37% | 289,274 | 3.35M |
| 49 | XWEL | XWELL, Inc. | 2.47M | 15.95% | 7,722,801 | 29.52M |